v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities    
Net loss $ (53,594) $ (88,378)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Allowance for expected credit losses 1,291 1,193
Depreciation and amortization 12,678 10,109
Amortization of deferred contract acquisition costs 13,911 13,769
Stock-based compensation expense 92,648 110,321
Net accretion of discount on marketable securities (362) (1,278)
Non-cash lease expense 9,930 9,122
Amortization of discount on revolving credit facility and term loan issuance costs 60 60
Changes in operating assets and liabilities, net of effects of business combinations:    
Accounts receivable 30,903 17,767
Prepaid expenses and other current assets (17,086) (20,179)
Other assets (1,452) 274
Accounts payable (3,506) 6,261
Accrued expenses and other liabilities (2,400) (12,170)
Deferred revenue 15,789 10,820
Operating lease liabilities (12,520) (11,092)
Net cash provided by operating activities 86,290 46,599
Cash flows from investing activities    
Cash paid for acquisition, net of acquired cash (71,616) 0
Purchases of marketable securities (81,750) (104,096)
Sales of marketable securities 133,603 0
Maturities of marketable securities 61,021 96,576
Purchases of property and equipment (4,302) (1,935)
Capitalized internal-use software costs (7,626) (5,287)
Net cash provided by (used in) investing activities 29,330 (14,742)
Cash flows from financing activities    
Repayment of term loan (3,750) (2,500)
Repurchases of common stock (96,526) (43,398)
Proceeds from exercise of stock options 1,340 2,073
Proceeds from employee stock purchase plan 4,874 7,746
Net cash used in financing activities (94,062) (36,079)
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash (1,405) 4,030
Net increase (decrease) in cash, cash equivalents, and restricted cash 20,153 (192)
Cash, cash equivalents, and restricted cash    
Beginning of period 200,253 184,864
End of period 220,406 184,672
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets    
Cash and cash equivalents 219,562 184,146
Restricted cash 844 526
Total cash, cash equivalents, and restricted cash 220,406 184,672
Supplemental cash flow data    
Cash paid for income taxes 3,003 1,259
Supplemental non-cash investing and financing information    
Purchase of property and equipment in accounts payable and accrued expenses and other current liabilities 1,096 182
Stock-based compensation expense capitalized for internal-use software $ 4,950 $ 3,555